PresbiBio Secures FDA Approval to Begin Phase II Trial of Presbia Flexivue Microlens Corneal Inlay

In a release, the Company noted: "This is an important step in making the Presbia Flexivue Microlens, a refractive solution for the treatment of presbyopia intended to reduce the dependency on reading glasses, available to more patients affected by this common age-related deterioration of near vision," said , Chief Technology Officer and inventor ... (more)

http://www.hispanicbusiness.com/2013/11/23/presbibio_secures_fda_approval_to_begin.htm